New framework defines core competencies for contemporary brain brachytherapy
The framework emphasizes multidisciplinary selection, source geometry, imaging, postimplant dosimetry, QA and radiation safety for modern intracranial Cs-131 brachytherapy.
The framework emphasizes multidisciplinary selection, source geometry, imaging, postimplant dosimetry, QA and radiation safety for modern intracranial Cs-131 brachytherapy.
At ten years after prostate LDR brachytherapy, 85% of respondents remained satisfied, while bowel quality of life remained independently associated with satisfaction.
Iodine-125 seed implantation produced 90% three-month disease control, but median local progression-free survival was nine months.
Iodine-125 doses of 140–160 grays were associated with longer median survival than 120–140 grays in recurrent glioblastoma.